- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes: a tipping point in neurodegenerative diseases
Authors
Keywords
-
Journal
TRENDS IN MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-11
DOI
10.1016/j.molmed.2023.09.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hallmarks of neurodegenerative diseases
- (2023) David M. Wilson et al. CELL
- Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases
- (2023) Dagfinn Aune et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis
- (2023) Qifan Zhong et al. Frontiers in Aging Neuroscience
- Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
- (2023) Jose A. Santiago et al. Frontiers in Aging Neuroscience
- Association of women-specific health factors in the severity of Parkinson’s disease
- (2023) Shilpa C. Rao et al. npj Parkinsons Disease
- Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite
- (2022) Isaac P. Heremans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progranulin as a therapeutic target in neurodegenerative diseases
- (2022) Herve Rhinn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Association between type 2 diabetes and amyotrophic lateral sclerosis
- (2022) Linjing Zhang et al. Scientific Reports
- Physical Activity Rewires the Human Brain against Neurodegeneration
- (2022) Jose A. Santiago et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses
- (2022) Botond Antal et al. eLife
- The Impact of Type 2 Diabetes in Parkinson's Disease
- (2022) Dilan Athauda et al. MOVEMENT DISORDERS
- Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
- (2022) Helena Chaytow et al. EBioMedicine
- Cerebrovascular insulin receptors are defective in Alzheimer’s disease
- (2022) Manon Leclerc et al. BRAIN
- Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of patients with diabetes based on their cognitive status
- (2022) Noriko Satoh-Asahara et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes Mellitus is Associated With Higher Serum Neurofilament Light Chain Levels in the General US Population
- (2022) Stefano Ciardullo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetes and Alzheimer's disease: shared genetic susceptibility?
- (2022) John Hardy et al. LANCET NEUROLOGY
- Physical activity intensity is associated with cognition and functional connectivity in Parkinson's disease
- (2022) Erin K. Donahue et al. PARKINSONISM & RELATED DISORDERS
- Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis
- (2022) Tianqi Zhang et al. Diabetes & Metabolism Journal
- Onset and mortality of Parkinson’s disease in relation to type II diabetes
- (2022) Gianni Pezzoli et al. JOURNAL OF NEUROLOGY
- Association between prediabetes and cognitive function in Parkinson's disease
- (2022) Joah Park et al. Brain and Behavior
- Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men
- (2021) Carola Deischinger et al. Journal of Parkinsons Disease
- Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
- (2021) Harneek Chohan et al. MOVEMENT DISORDERS
- Association Between Age at Diabetes Onset and Subsequent Risk of Dementia
- (2021) Claudio Barbiellini Amidei et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation
- (2021) Haimiao Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis
- (2021) Alexander G Thompson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Impaired brain insulin signalling in Parkinson's disease
- (2021) Fares Bassil et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Prediabetes, type 2 diabetes mellitus and risk of Parkinson’s disease: A population-based cohort study
- (2021) Almudena Sánchez-Gómez et al. PARKINSONISM & RELATED DISORDERS
- Association between diabetes mellitus and risk of Parkinson's disease: A prisma‐compliant meta‐analysis
- (2021) Wei Liu et al. Brain and Behavior
- Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2021) Xiaocui Qin et al. Frontiers in Neurology
- Diabetes duration and the risk of dementia: a cohort study based on German health claims data
- (2021) Constantin Reinke et al. AGE AND AGEING
- Antidiabetics, Statins, and the Risk of Amyotrophic Lateral Sclerosis
- (2020) Daniela Mariosa et al. EUROPEAN JOURNAL OF NEUROLOGY
- The multiplex model of the genetics of Alzheimer’s disease
- (2020) Rebecca Sims et al. NATURE NEUROSCIENCE
- Diabetes Mellitus Increases Risk of Incident Dementia in APOE ɛ4 Carriers: A Meta-Analysis
- (2020) Lily Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
- (2020) Sara Bandres-Ciga et al. NEUROBIOLOGY OF DISEASE
- Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
- (2020) Benjamin Meir Jacobs et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Peripheral insulin and amylin levels in Parkinson's disease
- (2020) Almudena Sánchez-Gómez et al. PARKINSONISM & RELATED DISORDERS
- Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy
- (2020) Ana Belen Malpartida et al. TRENDS IN BIOCHEMICAL SCIENCES
- Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease
- (2019) Dilan Athauda et al. JAMA Neurology
- Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
- (2019) Grazia Daniela Femminella et al. Trials
- Mitochondrial MsrB2 serves as a switch and transducer for mitophagy
- (2019) Seung Hee Lee et al. EMBO Molecular Medicine
- TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
- (2019) Kunihiko Araki et al. JOURNAL OF CLINICAL INVESTIGATION
- Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis
- (2019) Ching-Piao Tsai et al. JOURNAL OF NEUROLOGY
- Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
- (2019) Yang Hyun Lee et al. Scientific Reports
- Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
- (2019) Qian Shi et al. BMJ Open
- Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
- (2019) Ernesto Manzo et al. eLife
- Association between visit-to-visit variability of HbA1c and cognitive decline: a pooled analysis of two prospective population-based cohorts
- (2019) Zhe-Bin Yu et al. DIABETOLOGIA
- Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases
- (2019) Rong Cai et al. JOURNAL OF CLINICAL INVESTIGATION
- Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies
- (2019) Mei Xue et al. AGEING RESEARCH REVIEWS
- Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
- (2019) Yu Wang et al. Cell Reports
- Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
- (2019) Jose A. Santiago et al. Frontiers in Neuroscience
- Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
- (2019) Albert C. Ludolph et al. ANNALS OF NEUROLOGY
- Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics
- (2019) Ping Zeng et al. BMC Medicine
- The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China
- (2019) Linjing Zhang et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
- (2018) Fanfan Zheng et al. DIABETOLOGIA
- Hypermetabolism in ALS is associated with greater functional decline and shorter survival
- (2018) Frederik J Steyn et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Association between diabetes and subsequent Parkinson disease
- (2018) Eduardo De Pablo-Fernandez et al. NEUROLOGY
- High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
- (2018) Elliot Hogg et al. Journal of Parkinsons Disease
- Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease
- (2018) Margaret Schenkman et al. JAMA Neurology
- Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study
- (2018) Jie Zhen et al. Aging and Disease
- Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
- (2018) Amy Claxton et al. JOURNAL OF ALZHEIMERS DISEASE
- Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
- (2018) Seok Jong Chung et al. PARKINSONISM & RELATED DISORDERS
- Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
- (2018) Khadija Tayara et al. Frontiers in Cellular Neuroscience
- Finding diseases associated with amyotrophic lateral sclerosis: a total population-based case–control study
- (2018) Ching-Piao Tsai et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis
- (2017) P. Jésus et al. EUROPEAN JOURNAL OF NEUROLOGY
- The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis
- (2017) F. D'Ovidio et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
- (2017) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Diabetes is Not Associated with Alzheimer’s Disease Neuropathology
- (2017) Maria Niures Pimentel dos Santos Matioli et al. JOURNAL OF ALZHEIMERS DISEASE
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
- (2017) Qian-Qian Wei et al. Molecular Neurodegeneration
- Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS
- (2017) Babykumari P. Chitramuthu et al. PLoS One
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- Inducing mitophagy in diabetic platelets protects against severe oxidative stress
- (2016) Seung Hee Lee et al. EMBO Molecular Medicine
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)
- (2016) Leslie I. Grad et al. Cold Spring Harbor Perspectives in Medicine
- Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia
- (2016) Tze Pin Ng et al. JAMA Neurology
- Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
- (2016) Sabrina K. Hollinger et al. Frontiers in Neurology
- Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
- (2015) Saion Chatterjee et al. DIABETES CARE
- Association between diabetes and amyotrophic lateral sclerosis in Sweden
- (2015) D. Mariosa et al. EUROPEAN JOURNAL OF NEUROLOGY
- Progress of Diabetic Severity and Risk of Dementia
- (2015) Wei-Che Chiu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study
- (2015) Yu Sun et al. JOURNAL OF EPIDEMIOLOGY
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- (2015) Tiia Ngandu et al. LANCET
- Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
- (2015) Sabrina Paganoni et al. MUSCLE & NERVE
- Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis
- (2015) Cassie S. Mitchell et al. Neurodegenerative Diseases
- Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2015) W. Liu et al. NEUROSCIENCE
- DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death
- (2015) Deepak Jain et al. PLoS One
- Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease
- (2015) Jose A. Santiago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis
- (2015) Marianthi-Anna Kioumourtzoglou et al. JAMA Neurology
- Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
- (2015) Jose A. Santiago et al. PLoS One
- The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
- (2014) Christian Hölscher Alzheimers & Dementia
- Diabetes in Midlife and Cognitive Change Over 20 Years
- (2014) Andreea M. Rawlings et al. ANNALS OF INTERNAL MEDICINE
- Insulin resistance and gray matter volume in neurodegenerative disease
- (2014) J.K. Morris et al. NEUROSCIENCE
- PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1
- (2014) Raquel Requejo-Aguilar et al. Nature Communications
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance
- (2013) Hua Qu et al. MEDIATORS OF INFLAMMATION
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Glucose delays age-dependent proteotoxicity
- (2012) Arnaud Tauffenberger et al. AGING CELL
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Risk of Parkinson Disease Onset in Patients With Diabetes: A 9-year population-based cohort study with age and sex stratifications
- (2012) Y. Sun et al. DIABETES CARE
- Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
- (2012) G. Cheng et al. INTERNAL MEDICINE JOURNAL
- Insulin Promotes Neuronal Survival via the Alternatively Spliced Protein Kinase CδII Isoform
- (2012) André Apostolatos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
- (2012) Domenico Bosco et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Metabolic markers or conditions preceding Parkinson's disease: A case-control study
- (2012) Rodolfo Savica et al. MOVEMENT DISORDERS
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study
- (2012) G.O. Skeie et al. PARKINSONISM & RELATED DISORDERS
- Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
- (2012) Deepak Jain et al. Journal of Molecular Cell Biology
- Diabetes and the Risk of Developing Parkinson's Disease in Denmark
- (2011) E. Schernhammer et al. DIABETES CARE
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults
- (2011) Zaldy S. Tan et al. DIABETES CARE
- Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease
- (2011) Suzanne M. de la Monte DRUGS
- Early and Progressive Impairment of Spinal Blood Flow—Glucose Metabolism Coupling in Motor Neuron Degeneration of ALS Model Mice
- (2011) Kazunori Miyazaki et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Obesity, diabetes, and risk of Parkinson's disease
- (2011) Natalia Palacios et al. MOVEMENT DISORDERS
- α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion
- (2010) Xuehui Geng et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- ALS disease onset may occur later in patients with pre-morbid diabetes mellitus
- (2010) A. Jawaid et al. EUROPEAN JOURNAL OF NEUROLOGY
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Diabetes preceding Parkinson's disease onset. A case–control study
- (2009) Marco D'Amelio et al. PARKINSONISM & RELATED DISORDERS
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
- (2008) L. Dupuis et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now